1.云南中医药大学第一临床医学院,昆明 650000
2.云南省第一人民医院·昆明理工大学附属医院内分泌科,昆明 650000
Received:25 August 2022,
Published:28 November 2022
移动端阅览
邓真亭,牛奔,高洁,等.尿碘与甲状腺结节相关性及其恶性风险的研究[J].重庆医科大学学报,2022,47(11):1273-1277.
Deng Zhenting,Niu Ben,Gao Jie,et al.Study on the correlation between urinary iodine and thyroid nodules and its malignant risk[J].Journal of Chongqing Medical University,2022,47(11):1273-1277.
邓真亭,牛奔,高洁,等.尿碘与甲状腺结节相关性及其恶性风险的研究[J].重庆医科大学学报,2022,47(11):1273-1277. DOI: 10.13406/j.cnki.cyxb.003124.
Deng Zhenting,Niu Ben,Gao Jie,et al.Study on the correlation between urinary iodine and thyroid nodules and its malignant risk[J].Journal of Chongqing Medical University,2022,47(11):1273-1277. DOI: 10.13406/j.cnki.cyxb.003124.
目的
2
探究甲状腺结节与尿碘的相关性及其危险因素。
方法
2
选取2014年1月至2021年12月于云南省第一人民医院内分泌科进行甲状腺结节穿刺和参与“甲状腺疾病和碘营养状况的全国调查——2014”课题流调的人群为研究对象,经彩色多普勒超声检查及细胞病理学检查证实的甲状腺结节患者分为甲状腺良性结节组与甲状腺恶性结节组,合计3 206例。测定患者尿碘值、促甲状腺激素(thyroid stimulating hormone,TSH)、游离三碘甲状腺原氨酸(free triiodothyronine,FT3)、游离甲状素(free thyroxine,FT4)、甲状腺过氧化物酶抗体(thyroid peroxidase antibody,TPOAb)、甲状腺球蛋白抗体(thyroglobulin antibody, TGAb)、血生化等相关指标。采用SPSS 26.0软件进行
t
检验、秩和检验,危险因素采用多因素logistic回归分析。
结果
2
①甲状腺结节组尿碘含量(159.86 μg/L)低于健康人群(187.15 μg/L),差异有统计学意义。甲状腺结节组尿碘
<
100 μg/L的占比高于尿碘
>
300 μg/L者,甲状腺结节组碘含量构成比与健康人群比较,差异均有统计学意义(
P
<
0.01)。②甲状腺良性结节组尿碘水平中位数(134.70 μg/L)低于甲状腺恶性结节组尿碘水平中位数(172.83 μg/L)。③Logistic回归分析结果:性别当男性赋值为1,女性赋值为2时(
OR
=34.400,95%CI=1.619~730.759,
P
=0.023),女性患甲状腺恶性结节的风险大约增加33.4倍,尿碘(
OR=
1.018,95%CI=1.000~1.036,
P
=0.048)、FT4(
OR
=1.876,95%CI=1.081~3.254,
P
=0.025)、TPOAb(
OR
=0.948,95%CI=0.911~0.986,
P
=0.008)、甘油三酯(
OR
=2.523,95%CI=1.194~5.330,
P
=0.015)是甲状腺恶性结节发生的促进因素。
结论
2
尿碘、性别、FT4、TPOAb、甘油三酯与甲状腺恶性结节患病有关,促进甲状腺恶性结节发生。健康人群组碘含量分布与甲状腺结节组具有统计学差异。
Objective
2
To explore the correlation between thyroid nodules and urinary iodine and its risk factors.
Methods
2
From January 2014 to December 2021,people who had thyroid nodules puncture in the Department of Endocrinology,The First People's Hospital of Yunnan Province,and participated in the “National Survey of Thyroid Diseases and Iodine Nutrition Status–2014” were selected as the research object. The patients with thyroid nodules confirmed by color Doppler ultrasound and cytopathology were divided into the benign thyroid nodule group and the malignant thyroid nodule group with a total of 3 206 cases. Urinary iodine value,thyroid stimulating hormone(TSH),free triiodothyronine(FT3),free thyroxine(FT4),thyroid peroxidase antibody(TPOAb),thyroglobulin antibody(TGAb),blood biochemistry,and other related indicators were measured. SPSS 26.0 was used for
t
-test and rank sum test. Multivariate logistic regression analysis was used to analyze the risk factors.
Results
2
①The urinary iodine content(159.86 μg/L) in the thyroid nodule group was lower than that in the normal population(187.15 μg/L),and the difference was statistically significant. The proportion of urinary iodine
<
100 μg/L was higher than that of urinary iodine
>
300 μg/L in the thyroid nodule group,and the composition ratio of iodine content in the thyroid nodule group was statistically different from that in the normal population(
P
<
0.01). ②The median urinary iodine level in the benign thyroid nodule group (134.70 μg/L) was lower than that in the malignant thyroid nodule group(1
72.83 μg/L). ③According to the results of logistic regression analysis,as for gender, when the male assignment was 1 and the female assignment was 2(
OR
=34.400, 95%CI=1.619-730.759,
P
=0.023),the results showed that the risk of malignant thyroid nodules in women was 33.4 times higher than that in men. Urinary iodine(
OR
=1.018,95%CI=1.000-1.036,
P
=0.048),FT4(
OR
=1.876, 95%CI=1.081-3.254,
P
=0.025),TPOAb(
OR
=0.948,95%CI=0.911-0.986,
P
=0.008),triglyceride(
OR
=2.523, 95%CI=1.194-5.330,
P
=0.015) were the promoting factors for the occurrence of malignant thyroid nodules.
Conclusion
2
Urinary iodine,gender,FT4,TPOAb,and triglyceride are related to the prevalence of malignant thyroid nodules and promote the occurrence of malignant thyroid nodules. The distribution of iodine content in the normal group was significantly different from that in the thyroid nodule group.
Gharib MD H , Papini E , Paschke R , et al . American Association of Clinical Endocrinologists,Associazione Medici Endocrinologi,and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules:executive summary of recommendations [J ] . J Endocrinol Invest , 2010 , 33 ( 5 ): 287 - 291 .
陈雪霏 . 不同碘摄入量对甲状腺肿和甲状腺结节影响的前瞻性研究 [J ] . 中外医疗 , 2018 , 37 ( 20 ): 44 - 46 .
Chen XF . A prospective study of the effect of different iodine intake on goiter and thyroid nodule [J ] . China Foreign Med Treat , 2018 , 37 ( 20 ): 44 - 46 .
孙川喻 , 陆烨君 , 阮慧娟 , 等 . 成人碘营养状况评价以及与甲状腺结节的相关性 [J ] . 中华临床营养杂志 , 2016 , 24 ( 2 ): 76 - 81 .
Sun CY , Lu YJ , Ruan HJ , et al . Correlation between adult iodine nutrition and thyroid nodules [J ] . Chin J Clin Nutr , 2016 , 24 ( 2 ): 76 - 81 .
Tessler FN , Middleton WD , Grant EG , et al . ACR thyroid imaging,reporting and data system(TI-RADS):white paper of the ACR TI-RADS committee [J ] . J Am Coll Radiol , 2017 , 14 ( 5 ): 587 - 595 .
Shan ZY , Chen LL , Lian XL , et al . Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China:a cross-sectional study in 10 cities [J ] . Thyroid , 2016 , 26 ( 8 ): 1125 - 1130 .
Li YZ , Teng D , Ba JM , et al . Efficacy and safety of long-term universal salt iodization on thyroid disorders:epidemiological evidence from 31 provinces of mainland China [J ] . Thyroid , 2020 , 30 ( 4 ): 568 - 579 .
闫瑞霞 , 许 蕊 , 周 媛 , 等 . 河北沧州地区饮水中碘氟含量对成人甲状腺结节患病率的影响 [J ] . 中华地方病学杂志 , 2019 , 38 ( 6 ): 472 - 475 .
Yan RX , Xu R , Zhou Y , et al . Effects of iodine and fluoride content in drinking water on prevalence of adults thyroid nodules in Cangzhou,Hebei [J ] . Chin J Endem , 2019 , 38 ( 6 ): 472 - 475 .
Sun H , Wang HY , Lian XL , et al . Association between urinary iodine concentration and thyroid nodules in adults:a cross-sectional study in China [J ] . Biomed Res Int , 2020 , 2020 : 4138657 .
彭林平 , 陈利强 , 万 婷 , 等 . 广东省惠州地区甲状腺功能亢进及甲状腺结节患者尿碘结果分析 [J ] . 临床内科杂志 , 2019 , 36 ( 7 ): 491 - 492 .
Peng LP , Chen LQ , Wan T , et al . Analysis of urinary iodine in patients with hyperthyroidism and thyroid nodules in Huizhou,Guangdong Province [J ] . J Clin Intern Med , 2019 , 36 ( 7 ): 491 - 492 .
陈 赟 , 马维青 . 尿碘与甲状腺疾病相关性研究进展 [J ] . 临床与病理杂志 , 2016 , 36 ( 9 ): 1423 - 1429 .
Chen Y , Ma WQ . Research progress on the relationship between urinary iodine and thyroid disease [J ] . J Clin Pathol Res , 2016 , 36 ( 9 ): 1423 - 1429 .
Wang YH , Wang JG , Chen ZH , et al . Analysis of the correlation between high iodized salt intake and the risk of thyroid nodules:a large retrospective study [J ] . BMC Cancer , 2021 , 21 ( 1 ): 1000 .
Kim HJ , Park HK , Byun DW , et al . Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area [J ] . Eur J Nutr , 2018 , 57 ( 2 ): 809 - 815 .
Kim HJ , Kim NK , Park HK , et al . Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area [J ] . Eur J Nutr , 2017 , 56 ( 3 ): 965 - 971 .
Tang YZ , Yan TT , Wang G , et al . Correlation between insulin resistance and thyroid nodule in type 2 diabetes mellitus [J ] . Int J Endocrinol , 2017 , 2017 : 1617458 .
Hu L , Li T , Yin XL , et al . An analysis of the correlation between thyroid nodules and metabolic syndrome [J ] . Endocr Connect , 2020 , 9 ( 9 ): 933 - 938 .
Lee YK , Park KH , Park SH , et al . Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation [J ] . Head Neck , 2018 , 40 ( 10 ): 2271 - 2279 .
张美华 , 徐清芳 , 韩晨鹏 . 血清TgAb、TPOAb、TSH检测对良恶性甲状腺结节的鉴别诊断价值 [J ] . 中国实用医刊 , 2022 , 49 ( 1 ): 75 - 78 .
Zhang MH , Xu QF , Han CP . Value of serum TgAb,TPOAb and TSH detection in differential diagnosis of benign and malignant thyroid nodules [J ] . Chin J Pract Med , 2022 , 49 ( 1 ): 75 - 78 .
朱海清 , 张金苹 , 帅 瑛 , 等 . 抗甲状腺球蛋白抗体与>2.0 cm甲状腺结节恶性风险的相关性研究 [J ] . 中华全科医师杂志 , 2021 , 20 ( 2 ): 210 - 215 .
Zhu HQ , Zhang JP , Shuai Y , et al . Thyroglobulin antibody is associated with increased malignant risk of thyroid nodules & gt;2.0 cm [J ] . Chin J Gen Pract , 2021 , 20 ( 2 ): 210 - 215 .
Zhao HQ , Li HH , Huang T . High urinary iodine,thyroid autoantibodies,and thyroid-stimulating hormone for papillary thyroid cancer risk [J ] . Biol Trace Elem Res , 2018 , 184 ( 2 ): 317 - 324 .
Li LC , Shan TC , Sun XM , et al . Positive thyroid peroxidase antibody and thyroglobulin antibody are associated with better clinicopathologic features of papillary thyroid cancer [J ] . Endocr Pract , 2021 , 27 ( 4 ): 306 - 311 .
Zhang XF , Zhang XQ , Chang ZX , et al . Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer [J ] . J BUON , 2018 , 23 ( 5 ): 1467 - 1471 .
何 欢 , 彭艳文 , 刘 颖 , 等 . 糖尿病患者发生甲状腺结节的危险因素及与中医体质的相关性分析 [J ] . 国际中医中药杂志 , 2021 , 43 ( 4 ): 329 - 334 .
He H , Peng YW , Liu Y , et al . Risk factors of thyroid nodule in diabetic patients and the correlation with Traditional Chinese Medicine constitution [J ] . Int J Tradit Chin Med , 2021 , 43 ( 4 ): 329 - 334 .
苏 艳 , 刘 斌 , 朱盼盼 , 等 . 血脂水平变化与甲状腺乳头状癌的关系及临床意义 [J ] . 中国现代普通外科进展 , 2022 , 25 ( 6 ): 473 - 475 .
Su Y , Liu B , Zhu PP , et al . Relationship between serum lipids and thyroid papillary carcinoma and its clinical significance [J ] . Chin J Curr Adv Gen Surg , 2022 , 25 ( 6 ): 473 - 475 .
Zhang F , Li YZ , Yu XH , et al . The relationship and gender disparity between thyroid nodules and metabolic syndrome components based on a recent nationwide cross-sectional study and Meta-analysis [J ] . Front Endocrinol(Lausanne) , 2021 , 12 : 736972 .
0
Views
6
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
